ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101. A total of 91 filers reported holding ADURO BIOTECH INC in Q3 2017. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $2,244,000 | -1.6% | 305,311 | -6.2% | 0.09% | -2.2% |
| Q2 2018 | $2,280,000 | +34.3% | 325,660 | +53.9% | 0.09% | +30.4% |
| Q1 2018 | $1,698,000 | +46.9% | 211,646 | +37.3% | 0.07% | +32.7% |
| Q4 2017 | $1,156,000 | -1.2% | 154,140 | +40.4% | 0.05% | -17.5% |
| Q3 2017 | $1,170,000 | -4.1% | 109,815 | +2.6% | 0.06% | -37.6% |
| Q2 2017 | $1,220,000 | +43.5% | 107,057 | +35.4% | 0.10% | +20.2% |
| Q1 2017 | $850,000 | +13.2% | 79,046 | +20.0% | 0.08% | -7.7% |
| Q4 2016 | $751,000 | +4.2% | 65,874 | +13.6% | 0.09% | -5.2% |
| Q3 2016 | $721,000 | +5.7% | 57,990 | -3.8% | 0.10% | 0.0% |
| Q2 2016 | $682,000 | +13.3% | 60,298 | +28.4% | 0.10% | +159.5% |
| Q1 2016 | $602,000 | -14.6% | 46,962 | +87.5% | 0.04% | -58.4% |
| Q4 2015 | $705,000 | – | 25,046 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 2,106,734 | $40,807,000 | 12.39% |
| Rock Springs Capital Management LP | 415,000 | $8,039,000 | 0.65% |
| CLOUGH CAPITAL PARTNERS L P | 592,697 | $11,481,000 | 0.50% |
| NJ State Employees Deferred Compensation Plan | 53,300 | $1,032,000 | 0.22% |
| Orbimed Advisors | 1,065,522 | $20,639,000 | 0.21% |
| Point72 Asset Management, L.P. | 845,700 | $16,381,000 | 0.13% |
| LMCG INVESTMENTS, LLC | 244,382 | $4,734,000 | 0.10% |
| EverPoint Asset Management, LLC | 150,000 | $2,906,000 | 0.08% |
| M&T BANK CORP | 566,560 | $10,974,000 | 0.08% |
| GLOBEFLEX CAPITAL L P | 15,200 | $294,000 | 0.06% |